These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9091580)

  • 1. Role of the 5-lipoxygenase-activating protein (FLAP) in murine acute inflammatory responses.
    Byrum RS; Goulet JL; Griffiths RJ; Koller BH
    J Exp Med; 1997 Mar; 185(6):1065-75. PubMed ID: 9091580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory responses using 5-lipoxygenase- and leukotriene A4 hydrolase-deficient mice.
    Byrum RS; Goulet JL; Snouwaert JN; Griffiths RJ; Koller BH
    J Immunol; 1999 Dec; 163(12):6810-9. PubMed ID: 10586081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRP-187: A potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase/5-lipoxygenase-activating protein (FLAP) complex assembly.
    Garscha U; Voelker S; Pace S; Gerstmeier J; Emini B; Liening S; Rossi A; Weinigel C; Rummler S; Schubert US; Scriba GK; Çelikoğlu E; Çalışkan B; Banoglu E; Sautebin L; Werz O
    Biochem Pharmacol; 2016 Nov; 119():17-26. PubMed ID: 27592027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen-induced arthritis is reduced in 5-lipoxygenase-activating protein-deficient mice.
    Griffiths RJ; Smith MA; Roach ML; Stock JL; Stam EJ; Milici AJ; Scampoli DN; Eskra JD; Byrum RS; Koller BH; McNeish JD
    J Exp Med; 1997 Mar; 185(6):1123-9. PubMed ID: 9091585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of cytosolic phospholipase A2, 5-lipoxygenase and 5-lipoxygenase-activating protein in rat peritoneal macrophages during ovalbumin-induced sensitization.
    Escoubet-Lozach L; M'Rini C; Rey A; Béraud M; Lepert JC; Courtade M; Frisach MF; Pipy B
    Clin Exp Allergy; 2001 Jul; 31(7):1094-104. PubMed ID: 11468001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandins inhibit 5-lipoxygenase-activating protein expression and leukotriene B4 production from dendritic cells via an IL-10-dependent mechanism.
    Harizi H; Juzan M; Moreau JF; Gualde N
    J Immunol; 2003 Jan; 170(1):139-46. PubMed ID: 12496393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increases in 5-lipoxygenase activating protein expression account for enhanced capacity for 5-lipoxygenase metabolism that accompanies differentiation of peripheral blood monocytes into alveolar macrophages.
    Coffey MJ; Wilcoxen SE; Peters-Golden M
    Am J Respir Cell Mol Biol; 1994 Aug; 11(2):153-8. PubMed ID: 8049076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ amplification of 5-lipoxygenase and 5-lipoxygenase-activating protein in allergic airway inflammation and inhibition by leukotriene blockade.
    Chu SJ; Tang LO; Watney E; Chi EY; Henderson WR
    J Immunol; 2000 Oct; 165(8):4640-8. PubMed ID: 11035107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes.
    Kolaczkowska E; Shahzidi S; Seljelid R; van Rooijen N; Plytycz B
    Inflammation; 2002 Apr; 26(2):61-71. PubMed ID: 11989789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered inflammatory responses in leukotriene-deficient mice.
    Goulet JL; Snouwaert JN; Latour AM; Coffman TM; Koller BH
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12852-6. PubMed ID: 7809134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic factors determine the contribution of leukotrienes to acute inflammatory responses.
    Goulet JL; Byrum RS; Key ML; Nguyen M; Wagoner VA; Koller BH
    J Immunol; 2000 May; 164(9):4899-907. PubMed ID: 10779800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of AM803, a novel selective five-lipoxygenase-activating protein (FLAP) inhibitor in rodent models of acute inflammation.
    Lorrain DS; Bain G; Correa LD; Chapman C; Broadhead AR; Santini AM; Prodanovich PP; Darlington JV; Stock NS; Zunic J; King CD; Lee C; Baccei CS; Stearns B; Roppe J; Hutchinson JH; Prasit P; Evans JF
    Eur J Pharmacol; 2010 Aug; 640(1-3):211-8. PubMed ID: 20519143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced 5-lipoxygenase metabolism of arachidonic acid in macrophages rrom 1,25-dihydroxyvitamin D3-deficient rats.
    Coffey MJ; Wilcoxen SE; Phare SM; Simpson RU; Gyetko MR; Peters-Golden M
    Prostaglandins; 1994 Nov; 48(5):313-29. PubMed ID: 7855310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103), a novel selective 5-lipoxygenase-activating protein inhibitor that reduces acute and chronic inflammation.
    Lorrain DS; Bain G; Correa LD; Chapman C; Broadhead AR; Santini AM; Prodanovich P; Darlington JV; Hutchinson JH; King C; Lee C; Baccei C; Li Y; Arruda JM; Evans JF
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1042-50. PubMed ID: 19749079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of 12/15-lipoxygenase expression in peritoneal macrophages. Enhanced utilization of the 5-lipoxygenase pathway and diminished oxidation of low density lipoprotein.
    Sun D; Funk CD
    J Biol Chem; 1996 Sep; 271(39):24055-62. PubMed ID: 8798642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo sex differences in leukotriene biosynthesis in zymosan-induced peritonitis.
    Rossi A; Pergola C; Pace S; Rådmark O; Werz O; Sautebin L
    Pharmacol Res; 2014 Sep; 87():1-7. PubMed ID: 24892983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An experimental cell-based model for studying the cell biology and molecular pharmacology of 5-lipoxygenase-activating protein in leukotriene biosynthesis.
    Gerstmeier J; Weinigel C; Barz D; Werz O; Garscha U
    Biochim Biophys Acta; 2014 Sep; 1840(9):2961-9. PubMed ID: 24905297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase.
    Abramovitz M; Wong E; Cox ME; Richardson CD; Li C; Vickers PJ
    Eur J Biochem; 1993 Jul; 215(1):105-11. PubMed ID: 8344271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual 12/15- and 5-lipoxygenase deficiency in macrophages alters arachidonic acid metabolism and attenuates peritonitis and atherosclerosis in ApoE knock-out mice.
    Poeckel D; Zemski Berry KA; Murphy RC; Funk CD
    J Biol Chem; 2009 Jul; 284(31):21077-89. PubMed ID: 19509298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of 5-lipoxygenase-activating protein abrogates experimental liver injury: role of Kupffer cells.
    Titos E; Clària J; Planagumà A; López-Parra M; González-Périz A; Gaya J; Miquel R; Arroyo V; Rodés J
    J Leukoc Biol; 2005 Oct; 78(4):871-8. PubMed ID: 16033810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.